With the Securities and Exchange Commission (SEC) announcing the unsealing of fraud charges against a Mississippi company and its principal who allegedly &a;ldquo;bilked at least&a;rdquo; 150 investors in an $85 million&a;nbsp;&l;a href=&q;https://www.investor.gov/additional-resources/general-resources/glossary/ponzi-schemes&q; target=&q;_blank&q;&g;Ponzi scheme&l;/a&g;, it provides a reminder that such fraudulent investment scams are never far away and investors should watch out.
So named after&a;nbsp;Charles Ponzi, who duped investors back in the 1920s with a postage stamp speculation scheme that collected over $8 million from around 30,000 investors, Ponzi schemes were brought into sharp focus with&a;nbsp;&l;a href=&q;https://en.wikipedia.org/wiki/Bernard_Madoff&q; target=&q;_blank&q;&g;Bernard Madoff&l;/a&g;&a;nbsp;a decade ago in the late &a;ldquo;noughties&a;rdquo;, when he revealed his investments were &a;ldquo;all one big lie.&a;rdquo;
Hot High Tech Stocks To Buy Right Now: Regions Financial Corporation(RF)
Advisors' Opinion:- [By Shane Hupp]
Get a free copy of the Zacks research report on Regions Financial (RF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Get a free copy of the Zacks research report on Regions Financial (RF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
ValuEngine downgraded shares of Regions Financial (NYSE:RF) from a buy rating to a hold rating in a report published on Friday morning.
Several other equities research analysts also recently weighed in on the stock. Keefe, Bruyette & Woods reaffirmed a neutral rating on shares of Regions Financial in a research note on Sunday, April 22nd. B. Riley upped their target price on shares of Regions Financial from $19.00 to $20.00 and gave the stock a neutral rating in a research note on Tuesday, April 24th. Three equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating, four have given a buy rating and two have assigned a strong buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus price target of $17.56.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Regions Financial (RF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Get a free copy of the Zacks research report on Regions Financial (RF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Hot High Tech Stocks To Buy Right Now: iShares MSCI Emerging Markets (EEM)
Advisors' Opinion:- [By Ethan Ryder]
Cabot Wealth Management Inc. raised its stake in iShares MSCI Emerging Markets ETF (NYSEARCA:EEM) by 10.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 31,676 shares of the exchange traded fund’s stock after buying an additional 2,946 shares during the quarter. Cabot Wealth Management Inc.’s holdings in iShares MSCI Emerging Markets ETF were worth $1,529,000 at the end of the most recent quarter.
- [By Ethan Ryder]
Summit X LLC boosted its position in shares of iShares MSCI Emerging Markets ETF (NYSEARCA:EEM) by 15.6% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 9,837 shares of the exchange traded fund’s stock after acquiring an additional 1,325 shares during the period. Summit X LLC’s holdings in iShares MSCI Emerging Markets ETF were worth $429,000 as of its most recent filing with the SEC.
- [By ]
In the first three months of the year, Bridgewater unloaded more than $2 billion worth of shares in three big emerging market ETFs: the iShares MSCI Emerging Markets ETF (EEM), its cheaper counterpart the iShares Core MSCI Emerging Markets ETF (IEMG), and the Vanguard FTSE Emerging Markets ETF (VWO). The combined 45 million shares were the largest sales by the money manager in the period.
- [By ]
The MSCI Emerging Market Index is positing an incredible run. It's on its longest-ever streak without a 10% decline, Bloomberg notes. That's helping power the iShares MSCI Emerging Markets ETF (NYSE:EEM) well ahead of the S&P 500 to start the year.
- [By Jim Crumly]
Materials stocks rebounded from a fall yesterday, with the SPDR S&P Metals and Mining ETF (NYSEMKT:XME) closing up 2%. Emerging markets also bounced back, thanks in part to a weakening dollar; the iShares MSCI Emerging Markets ETF (NYSEMKT:EEM) rose 1.9%.
- [By Joseph Griffin]
First Trust Advisors LP purchased a new stake in shares of iShares MSCI Emerging Markets ETF (NYSEARCA:EEM) in the second quarter, HoldingsChannel.com reports. The institutional investor purchased 17,676 shares of the exchange traded fund’s stock, valued at approximately $766,000.
Hot High Tech Stocks To Buy Right Now: Semtech Corporation(SMTC)
Advisors' Opinion:- [By Benzinga News Desk]
The wealthy are hoarding $10 billion of bitcoin in bunkers: Link $
ECONOMIC DATA US May MBA mortgage applications -0.4% vs, -2.5% prior USA Core PPI (MoM) for Apr 0.20% vs 0.20% Est; Prior 0.30%. USA PPI (MoM) for Apr 0.10% vs 0.20% Est; Prior 0.30% Data on wholesale trade inventories for March will be released at 10:00 a.m. ET. The Energy Information Administration’s weekly report on petroleum inventories in the U.S. is schedule for release at 10:30 a.m. ET. The Treasury is set to auction 10-year notes at 1:00 p.m. ET. Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 1:15 p.m. ET. ANALYST RATINGS Cantor upgraded Arrowhead Pharmaceuticals (NASDAQ: ARWR) from Neutral to Overweight RBC upgraded Semtech (NASDAQ: SMTC) from Sector Perform to Outperform Morgan Stanley downgraded Adient (NYSE: ADNT) from Overweight to Equal-Weight Jefferies downgraded Beacon Roofing (NASDAQ: BECN) from Buy to HoldThis is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.
- [By Shane Hupp]
Semtech Co. (NASDAQ:SMTC) – Investment analysts at Oppenheimer issued their Q3 2020 earnings estimates for shares of Semtech in a research note issued to investors on Thursday, May 31st. Oppenheimer analyst R. Schafer anticipates that the semiconductor company will post earnings per share of $0.45 for the quarter. Oppenheimer currently has a “Outperform” rating and a $50.00 price target on the stock. Oppenheimer also issued estimates for Semtech’s Q4 2020 earnings at $0.44 EPS.
- [By Motley Fool Transcription]
Semtech Corporation (NASDAQ:SMTC)Q2 2019 Earnings Conference CallAug. 29, 2018, 5:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Stephan Byrd]
Semtech (NASDAQ:SMTC)‘s stock had its “overweight” rating reaffirmed by equities researchers at Piper Jaffray Companies in a report released on Monday, The Fly reports. They presently have a $57.00 price target on the semiconductor company’s stock. Piper Jaffray Companies’ price target would indicate a potential upside of 12.98% from the stock’s current price.
- [By Logan Wallace]
Semtech Co. (NASDAQ:SMTC) VP Marc Pegulu sold 500 shares of the firm’s stock in a transaction on Friday, July 6th. The shares were sold at an average price of $48.85, for a total value of $24,425.00. Following the completion of the sale, the vice president now owns 15,453 shares in the company, valued at $754,879.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
- [By Ethan Ryder]
Semtech Co. (NASDAQ:SMTC) SVP James Jungsup Kim sold 8,617 shares of Semtech stock in a transaction on Tuesday, September 18th. The stock was sold at an average price of $60.00, for a total value of $517,020.00. Following the completion of the transaction, the senior vice president now owns 54,842 shares in the company, valued at $3,290,520. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
No comments:
Post a Comment